These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 643163

  • 1. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.
    Kelly PH, Moore KE.
    Neuropharmacology; 1978 Mar; 17(3):169-74. PubMed ID: 643163
    [No Abstract] [Full Text] [Related]

  • 2. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE.
    Adv Biochem Psychopharmacol; 1977 Mar; 16():495-9. PubMed ID: 18898
    [No Abstract] [Full Text] [Related]

  • 3. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT, Fibiger HC.
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract] [Full Text] [Related]

  • 4. Spontaneous and amphetamine-induced behavior after bilateral injection of ethanolamine-O-sulfate into the substantia nigra.
    Koob GF, Del Fiacco M, Iversen SD.
    Brain Res; 1978 May 12; 146(2):313-23. PubMed ID: 565665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine.
    Kamata K, Rebec GV.
    Brain Res; 1984 Oct 29; 321(1):147-50. PubMed ID: 6498510
    [Abstract] [Full Text] [Related]

  • 11. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ, György L.
    Acta Physiol Acad Sci Hung; 1981 Oct 29; 58(3):225-33. PubMed ID: 7348023
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A, Cecchetti G, Ghezzi D, Samanin R.
    Eur J Pharmacol; 1974 May 29; 26(2):179-83. PubMed ID: 4859224
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S, Kamal LA, Langer SZ.
    Br J Pharmacol; 1981 Oct 29; 74(2):389-97. PubMed ID: 7317688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding.
    Waddington JL, Cross AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr 29; 306(3):275-80. PubMed ID: 471079
    [Abstract] [Full Text] [Related]

  • 16. Function of nigral dopamine receptors?
    Glick SD, Crane LA.
    Brain Res; 1978 Nov 10; 156(2):380-1. PubMed ID: 568507
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GABA-induced locomotor activity in the rat, after bilateral injection into the ventral tegmental area.
    Tanner T.
    Neuropharmacology; 1979 May 10; 18(5):441-6. PubMed ID: 460540
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT, Lawson-Wendling KL, Moore KE.
    Biochem Pharmacol; 1983 Feb 15; 32(4):691-7. PubMed ID: 6403019
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.